Agios Pharmaceuticals Inc (AGIO) Directors and Executive Officers

Officers & Directors

Cynthia Smith
Director

Kaye Foster
Director

Cecilia Jones
Chief Financial Officer (Principal financial officer)

Rahul Ballal
Director

Maykin Ho
Director

T.J. Washburn
Vice President, Controller (Principal accounting officer)

Catherine Owen
Director

David Scadden
Director

Jeffrey Capello
Director

David P. Schenkein
Director

Jacqualyn A. Fouse
Chair of the Board of Directors

Brian Goff
Chief Executive Officer (Principal executive officer)

Boston, Massachusetts ,

Agios Pharmaceuticals Inc currently has 540 employees.

News about Agios Pharmaceuticals Inc Key Personnel

“Agios Pharmaceuticals Sees Strong Q4 Performance and Advances Mitapivat to Transform Thalassemia Treatment”,

Agios Pharmaceuticals Reports Q4 and Full Year 2024 Financial Results, Advances Mitapivat for Thalassemia TreatmentAgios Pharmaceuticals Inc. a biopharmaceutical company focused on discovering and developing innovative therapies for rare diseases, has announced its financial results for the fourth quarter and full year of 2024. The report highlights significant advancements in the company s lead product, Mitapivat (commercially known as PYRUKYND), as Agios seeks to obtain regulatory approval for its use in treating adult patients diagnosed with both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia. Financial Performance OverviewIn a year marked by significant developments and ch...